<DOC>
	<DOCNO>NCT02066103</DOCNO>
	<brief_summary>Assess safety feasibility local oncological drug delivery bronchial wall recanalization subject malignant airway obstruction . Safety feasibility ( technical success ) assess . This localized delivery intend adjunct therapy subject receive standard care oncology therapy determine treat physician .</brief_summary>
	<brief_title>Broncho-Adventitial Delivery Paclitaxel Extend Airway Patency Malignant Airway Obstruction Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Airway Obstruction</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Life expectancy least 12 week Adequate bone marrow , liver , renal function Scheduled undergo bronchoscopy malignant airway obstruction standard medical care Pathologically confirm , unresectable primary recurrent nonsmall cell lung cancer Measurable disease obstruction airway Pathologically confirm , unresectable primary recurrent nonsmall cell lung cancer Patients undergo recanalization procedure tumor bronchoscopy Investigator able insert deploy Blowfish Catheter airway recanalization Second primary malignancy , except nonmelanoma skin cancer situ cervical cancer Pregnant nursing female subject , female subject child bear potential refuse take pregnancy test prior enrollment study Uncontrolled infection Presence recent history systemic disorder condition , : uncontrolled hypertension type 1 diabetes severe pulmonary hypertension acute kidney injury stroke ( within last 6 month ) myocardial infarction ( within last 3 month ) Individuals neurological , mental psychiatric disorder Concurrent participation another study involve investigational drug investigational medical device Other ( noncancer ) disease stabilize within 1 month Screening Visit Known hypersensitivity paclitaxel , Cremophor EL , iodinate contrast medium Any serious , uncontrolled comorbidity condition Investigator believe would interfere intent study would make participation best interest patient Intraoperative Exclusion Criteria Use pulmonary airway stent and/or ongoing initiation local external beam brachytherapy radiation Any intraoperative complication per investigator 's judgment increase risk patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>